Fidelity Investments’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
Fidelity Investments's IMRX Position: Q3 2026 in Review
Fidelity Investments reduced its Immuneering (IMRX) stake by 5.3% in Q3 2026, selling an estimated $2.42M and leaving 9,193,275 shares worth $37.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.
Fidelity Investments first reported a position in IMRX in Q3 2021 and has held it in 18 quarters since. The position peaked at $63.7M in Q4 2025. 131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- Fidelity Investments held 9,193,275 shares of Immuneering worth $37.6M as of Q3 2026.
- Fidelity Investments sold 511,335 Immuneering shares in Q3 2026, an estimated $2.42M.
- Immuneering made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1624 holding.
- Fidelity Investments first reported a position in Immuneering in Q3 2021 and has held it in 18 quarters since.
- Fidelity Investments's Immuneering position peaked at $63.7M in Q4 2025.
- 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.